|Stock Name : Morepen Laboratories Limited/Tips Open||Buy : 30||Posted Date : Nov 26, 2020|
|Stopless/Horizon : 28||Target : 35||Results Achieved (Yes/No) :|
Morepen Laboratories limited, headquartered in New Delhi India,is 27 years old company. went to public in 1993. The brand name of Dr. Morepan has a front ranking presence in the wellness category. its spectrum of popular products,amongst which burnol, lemolate, sat isabgol,C-Sip,Dab,C-Candy,Y-Sugar and many more are undisputable household names have a spread relief and cheer in many house and lives. Manufacturer and exporter of complex and high margin Molecules for regulated markets of USA, Europe, Russia, Canada and also for non regulated markets.
Markets over hundred branded formulations in eight major therapeutic segments and under its own brand name clinical and home health devices and blood bank machines. Possess complex chemistry skills like chiral synthesis,Grignard reaction,Friedel craft reaction high blood pressure hydrogenation, alkylation and bromination ect.
Shri Sushil Suri chairman and managing director of the company.
Share holding pattern as on 30 June 2020 Promoter and promoter group 34.54% and Public 65.46%.
Morepen laboratories consolidated net profit rise 565.93% in September 2020 Quarter.net profit of Morepen laboratories Rose 565.93% to Rs. 27.17 crore in the quarter ended September 2020 as against Rs. 4.08 crore during the previous quarter ended September 2019. Sales Rose 57.62% to 336.40 crore in the quarter ended September 2020 as against Rs.213.43 during the previous quarter ended September 2019.
If you find any mistake please contact the email@example.com. This article is general in nature. It does not constitute a recommendation to buy and sell any stock, and does not take account of your objectives, or your financial situation. Largecapindia has no position in the stocks mentioned.
Largecapindia aim to bring you long term focused research analysis driven by fundamental thanks you.
For More Info : https://www.largecapindia.com